STADA Group in the news

Stada introduced Elotrans Hydrate, a new ready-to-drink electrolyte beverage, for food retail, complementing its existing pharmacy-only Elotrans range.

STADA and SBP Group subsidiary CTTQ launched a strategic partnership for biosimilars, including a Keytruda biosimilar, to expand patient access across key markets.

STADA Group partners with SBP Group and CTTQ to develop and commercialize a Pembrolizumab biosimilar and other molecules, accelerating its growth in the biosimilars market.

STADA and SBP Group's CTTQ are partnering on biosimilars, including a Keytruda biosimilar, for exclusive marketing by STADA in several regions, aiming to boost patient access.

Stada Arzneimittel opened a new 75-million-dollar supply chain and packaging facility in Turda, Romania, significantly increasing its capacity for manufacturing pharmaceuticals.

Aliud Pharma, a STADA Group subsidiary, is a significant German generics manufacturer led by CEO Basem Yazgi, known for its cost-saving business model and extensive product portfolio.

STADA Group appointed Diana Wiedmann as Chief Culture & People Officer, effective January 1, 2027, leveraging her 25 years of experience to foster high-performance culture and growth.

STADA appoints Diana Wiedmann as Chief Culture & People Officer, effective January 1, 2027.

STADA Group appointed Diana Wiedmann as Chief Culture & People Officer, effective January 1, 2027, bringing 25 years of experience in HR, consulting, strategy, and banking to the role.

Bundestag member Dr. Thomas Pauls visited STADA's Florstadt warehouse to observe pharmaceutical distribution, discuss regulatory challenges, and advocate for strengthening domestic logistics and production.

STADA appointed Diana Wiedmann as Chief Culture & People Officer, effective January 1, 2027, leveraging her extensive international HR and biopharma experience.

STADA has successfully integrated its corporate values into its employee compensation system, leading to positive financial results and improved workplace culture over seven years.

Serbia has the lowest fear of aging in Europe, according to the STADA Health Report 2026.

STADA has made 9 acquisitions in various sectors and countries, with the latest being PHYTO in August 2024, and has also been the subject of an acquisition by CapVest.

STADA appointed former Reckitt executive Mark Pearson as Head and EVP, Global Consumer Healthcare, aiming to accelerate growth in this sector.

STADA was denied a speedy trial in a patent dispute over a Novartis heart failure drug due to delayed filing.

Stada acquired 16 vitamin, mineral, and food supplement brands from Orifarm to bolster its presence in Nordic countries, Belgium, and Poland.

Stada acquired 16 European consumer health brands from Orifarm, including vitamins, minerals, and supplements, to expand its market presence under new ownership.

STADA Group acquired 16 vitamin, mineral, and food supplement brands from Orifarm to expand its over-the-counter health product business.

Stada acquired 16 vitamin, mineral, and supplement brands from Orifarm to boost its market presence in Nordic countries, Belgium, and Poland.